Inmode Ltd(INMD) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 4:15 PM ET (Korea 9/12 05:15)
Full metrics table
| Index | - | P/E | 12.09 | EPS (ttm) | 1.23 | Insider Own | 16.39% | Shs Outstand | 57.5M | Perf Week | 0.4% |
| Market Cap | 0.86B | Forward P/E | 10.86 | EPS next Y | 5.86% | Insider Trans | - | Shs Float | 48.1M | Perf Month | -2.17% |
| Enterprise Value | 0.36B | PEG | - | EPS next Q | 0.32 | Inst Own | 52.83% | Short Float | 4.89% | Perf Quarter | 10.45% |
| Income | 0.08B | P/S | 2.29 | EPS this Y | -19% | Inst Trans | -4.07% | Short Ratio | 3.8 | Perf Half Y | 16.77% |
| Sales | 0.37B | P/B | 1.36 | EPS next 5Y | -3.27% | ROA | 10.85% | Short Interest | 2.35M | Perf YTD | 1.43% |
| Book/sh | 10.95 | P/C | 1.71 | EPS past 3/5Y | -9.87% 6.62% | ROE | 12.33% | 52W High | -10.99% ($16.74) | Perf Year | -2.87% |
| Cash/sh | 8.72 | P/FCF | 9.69 | Sales past 3/5Y | -6.57% 12.44% | ROIC | 12.23% | 52W Low | 17.14% ($12.72) | Perf 3Y | -60.57% |
| Dividend Est. | - | EV/EBITDA | 5.15 | EPS Y/Y TTM | -50.25% | Gross Margin | 76.52% | Volatility(W/M) | 1.55% 1.32% | Perf 5Y | -78.11% |
| Dividend TTM | - | EV/Sales | 0.96 | Sales Y/Y TTM | -6.71% | Oper. Margin | 18.47% | ATR (14) | 0.22 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 7.28 | EPS Q/Q | -31.6% | Profit Margin | 20.69% | RSI (14) | 47.85 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 8.18 | Sales Q/Q | -0.01% | SMA20 | -0.3% ($14.94) | Beta | 2.02 | Target Price | $16.17 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2026/8/5 | SMA50 | -1.13% ($15.07) | Rel Volume | 0.73 | Prev Close | $14.77 |
| Employees | 660 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | 1.16% 0.74% | SMA200 | 3.56% ($14.39) | Avg Volume(3M) | 0.62M | Price | $14.9 |
| IPO | 2019/8/8 | Option/Short | Yes/Yes | Trades | 6208 | Volume | 450,629 | Change | 0.88% |
Company
INMD is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
💆 InMode (INMD) is a healthcare company that develops and sells radiofrequency- and laser-based aesthetic medical device platforms. It supplies physicians with equipment that enables non-surgical procedures such as body contouring, skin tightening, and wrinkle reduction. Its business model combines equipment sales with disposable applicators, creating a stable, recurring revenue structure.
Over the past 1 year, roughly in the middle
11% below its 1-year high.
INMD makes money exceptionally well
18.47% of revenue is kept as operating profit.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -19.0% this year.
Tap to view numbers
The stock looks undervalued
Trading at 12.1 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Would have changed by -60.6% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 52.8%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
IZRL 0.02%
DEEP 0.01%
JPSV 0.01%
ISRA 0.01%
AFSM 0.00%It ranks #4 in the industry
Based on market cap of $856M.
INMD $856M PER 12.1
ABT $176B PER 33.0
MDT $116B PER 22.4
SYK $106B PER 28.6
FAQ
What kind of company is INMD?
INMD belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of INMD?
The market cap of INMD is approximately $856M, ranking 2,773 within its sector.
What is the P/E ratio of INMD?
INMD has a P/E ratio of approximately 12.1x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for INMD?
INMD has recorded a 52-week high of $16.74 and a low of $12.72.
